1. Home
  2. TECX vs SHBI Comparison

TECX vs SHBI Comparison

Compare TECX & SHBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$29.35

Market Cap

393.0M

Sector

N/A

ML Signal

HOLD

Logo Shore Bancshares Inc

SHBI

Shore Bancshares Inc

HOLD

Current Price

$18.10

Market Cap

601.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
SHBI
Founded
2019
1876
Country
United States
United States
Employees
51
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
393.0M
601.1M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
TECX
SHBI
Price
$29.35
$18.10
Analyst Decision
Strong Buy
Buy
Analyst Count
5
3
Target Price
$80.40
$19.17
AVG Volume (30 Days)
289.9K
204.1K
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
2.62%
EPS Growth
N/A
34.85
EPS
N/A
1.78
Revenue
N/A
$20,853,000.00
Revenue This Year
N/A
$9.16
Revenue Next Year
N/A
$6.71
P/E Ratio
N/A
$10.31
Revenue Growth
N/A
N/A
52 Week Low
$13.70
$11.47
52 Week High
$35.99
$20.68

Technical Indicators

Market Signals
Indicator
TECX
SHBI
Relative Strength Index (RSI) 52.77 45.10
Support Level $16.43 $17.32
Resistance Level $35.99 $19.31
Average True Range (ATR) 2.01 0.47
MACD -0.57 0.07
Stochastic Oscillator 18.55 56.69

Price Performance

Historical Comparison
TECX
SHBI

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About SHBI Shore Bancshares Inc

Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in one business segment- banking. The company's primary source of revenue is derived from interest earned on commercial, residential mortgage and other loans, and fees charged in connection with lending and other banking services located in Maryland, Delaware and Virginia.

Share on Social Networks: